• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy.

作者信息

Maurizi Niccolò, Michels Michelle, Rowin Ethan J, Semsarian Christopher, Girolami Francesca, Tomberli Benedetta, Cecchi Franco, Maron Martin S, Olivotto Iacopo, Maron Barry J

机构信息

Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy (N.M., F.G., B.T., F.C., I.O.).

Erasmus Medical Center, Rotterdam, The Netherlands (M.M.).

出版信息

Circulation. 2019 Feb 5;139(6):830-833. doi: 10.1161/CIRCULATIONAHA.118.037264.

DOI:10.1161/CIRCULATIONAHA.118.037264
PMID:30715937
Abstract
摘要

相似文献

1
Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy.无左心室肥厚的肥厚型心肌病的临床病程及意义
Circulation. 2019 Feb 5;139(6):830-833. doi: 10.1161/CIRCULATIONAHA.118.037264.
2
Altered autonomic cardiac control in hypertrophic cardiomyopathy. Role of outflow tract obstruction and myocardial hypertrophy.肥厚型心肌病中自主神经对心脏控制的改变。流出道梗阻和心肌肥厚的作用。
Eur Heart J. 1998 Jan;19(1):146-53. doi: 10.1053/euhj.1997.0743.
3
QT dispersion and left ventricular morphology in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者的QT离散度与左心室形态
Heart. 2003 Aug;89(8):882-6. doi: 10.1136/heart.89.8.882.
4
Clinical characteristics and outcomes of hypertrophic cardiomyopathy in Taiwan--a tertiary center experience.台湾肥厚型心肌病的临床特征与预后——来自三级医疗中心的经验
Clin Cardiol. 2007 Apr;30(4):177-82. doi: 10.1002/clc.20057.
5
Natural history of hypertrophic cardiomyopathy: Japanese experience.肥厚型心肌病的自然病史：日本的经验。
J Cardiol. 2001;37 Suppl 1:147-54.
6
Development of obstructive hypertrophic cardiomyopathy from nonobstructive hypertrophic cardiomyopathy.非梗阻性肥厚型心肌病进展为梗阻性肥厚型心肌病。
Am J Cardiol. 1998 Aug 1;82(3):403-5. doi: 10.1016/s0002-9149(98)00337-3.
7
Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy.肥厚型心肌病和严重左心室肥厚患者的进行性左心室重塑。
J Am Coll Cardiol. 2004 Jul 21;44(2):398-405. doi: 10.1016/j.jacc.2004.01.054.
8
Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III.肥厚型心肌病与Ⅲ型糖原贮积病中左心室肥厚的功能意义比较。
Am J Cardiol. 1997 Mar 15;79(6):834-8. doi: 10.1016/s0002-9149(96)00885-5.
9
Transthyretin Amyloidosis Mimicking Obstructive Hypertrophic Cardiomyopathy: A Great Imitator.模仿梗阻性肥厚型心肌病的转甲状腺素蛋白淀粉样变性：一个强大的模仿者。
Heart Lung Circ. 2019 May;28(5):e108-e110. doi: 10.1016/j.hlc.2018.11.021. Epub 2018 Dec 27.
10
A standard echocardiographic and tissue Doppler study of morphological and functional findings in children with hypertrophic cardiomyopathy compared to those with left ventricular hypertrophy in the setting of Noonan and LEOPARD syndromes.一项标准超声心动图和组织多普勒研究，比较肥厚型心肌病患儿与努南综合征和豹皮综合征背景下左心室肥厚患儿的形态学和功能学表现。
Cardiol Young. 2008 Dec;18(6):575-80. doi: 10.1017/S104795110800320X. Epub 2008 Oct 9.

引用本文的文献

1
Development of conditional-siRNA programmable riboswitch for targeting adverse cardiac remodeling.用于靶向不良心脏重塑的条件性小干扰RNA可编程核糖开关的开发。
Mol Ther Nucleic Acids. 2025 Aug 5;36(3):102667. doi: 10.1016/j.omtn.2025.102667. eCollection 2025 Sep 9.
2
Austrian consensus statement on the diagnosis and management of hypertrophic cardiomyopathy.奥地利肥厚型心肌病诊断与管理共识声明
Wien Klin Wochenschr. 2024 Oct;136(Suppl 15):571-597. doi: 10.1007/s00508-024-02442-1. Epub 2024 Oct 1.
3
Evaluation of potential links between phenotypic features and genetic variants in left ventricular outflow tract obstruction in hypertrophic cardiomyopathy using cardiovascular magnetic resonance imaging.
运用心血管磁共振成像评估肥厚型心肌病左心室流出道梗阻的表型特征与基因变异之间的潜在关联。
Int J Cardiovasc Imaging. 2024 Nov;40(11):2417-2428. doi: 10.1007/s10554-024-03250-4. Epub 2024 Sep 30.
4
Deciphering metabolomics and lipidomics landscape in zebrafish hypertrophic cardiomyopathy model.解析斑马鱼肥厚型心肌病模型中的代谢组学和脂质组学图谱。
Sci Rep. 2024 Sep 19;14(1):21902. doi: 10.1038/s41598-024-72863-5.
5
Metabolic characterization of hypertrophic cardiomyopathy in human heart.人类心脏肥厚型心肌病的代谢特征
Nat Cardiovasc Res. 2022 May;1(5):445-461. doi: 10.1038/s44161-022-00057-1. Epub 2022 May 9.
6
Guidelines on the Diagnosis and Treatment of Hypertrophic Cardiomyopathy - 2024.肥厚型心肌病诊断与治疗指南 - 2024
Arq Bras Cardiol. 2024 Jul 26;121(7):e202400415. doi: 10.36660/abc.20240415.
7
Major Cardiac Events in Patients and Relatives With Hereditary Hypertrophic Cardiomyopathy.遗传性肥厚型心肌病患者及其亲属的主要心脏事件
JACC Adv. 2023 Sep 12;2(8):100604. doi: 10.1016/j.jacadv.2023.100604. eCollection 2023 Oct.
8
Genotype-Phenotype Insights of Inherited Cardiomyopathies-A Review.遗传性心肌病的基因型-表型见解——综述
Medicina (Kaunas). 2024 Mar 27;60(4):543. doi: 10.3390/medicina60040543.
9
A pathogenic nonsense mutation (c.1522C>T) of the MYBPC3 gene is implicated with hypertrophic cardiomyopathy.一个致病性的无义突变（c.1522C>T）被认为与肥厚型心肌病有关。
ESC Heart Fail. 2023 Aug;10(4):2711-2717. doi: 10.1002/ehf2.14424. Epub 2023 Jun 4.
10
Is There a Sex Difference in the Prognosis of Hypertrophic Cardiomyopathy? A Systematic Review and Meta-Analysis.肥厚型心肌病的预后是否存在性别差异？系统评价和荟萃分析。
J Am Heart Assoc. 2023 Jun 6;12(11):e026270. doi: 10.1161/JAHA.122.026270. Epub 2023 May 26.